Vera Therapeutics recently appointed Matt Skelton as Chief Commercial Officer, effective January 28, 2026, elevating him from his prior role as Executive Vice President, Commercial to lead ...

By pairing customer-focused innovation with consistent trust-building, brands can move beyond transactions to earn lasting ...

An open-ended strike at Kaiser Permanente hospitals in California and Hawaii continued into the second week on Monday, with ...

Xeris Biopharma is showing strong growth and improving EBITDA, especially driven by its blockbuster drug Recorlev. Learn why ...

Generic medications are not the same as brand medications. Small differences in ingredients that are permitted by the FDA may ...

From revolutionary tech founders to self-made business icons, this article highlights the Top 10 Trailblazing Entrepreneurs ...

At the end of 2025, our outlook for U.S. small-cap stocks is optimistic, driven by favorable macroeconomic trends and easing ...

Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

ARBLI ™ is the first and only oral liquid formulation of losartan approved by the U.S. FDA. ARBLI ™ comes in a 165 mL bottle as a peppermint flavored suspension that does not require refrigeration, ...

"We are delighted that the clinical development of these promising therapeutics will continue at NeoTrail with an opportunity to deliver patient benefit in multiple major market indications,” stated ...

Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapyTraumatic ...

AI slop is getting worse. A big trouble is how AI slop is going to undermine AI-generated mental health advice. I layout the specifics. An AI Insider scoop.